tradingkey.logo
搜尋

Intellia Therapeutics Inc

NTLA
添加自選
10.680USD
-0.410-3.70%
收盤 07-31 16:00美東報價延遲15分鐘
1.49B總市值
虧損本益比TTM

NTLA 利潤表

您可以在這裡找到Intellia Therapeutics Inc的年度或季度收入報告,以深入了解Intellia Therapeutics Inc的營運、管理效率和表現。
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
FY2018Q4
FY2018Q3
FY2018Q2
FY2018Q1
FY2017Q4
FY2017Q3
FY2017Q2
FY2017Q1
FY2016Q4
FY2016Q3
FY2016Q2
FY2016Q1
FY2015Q4
FY2015Q3
FY2015Q2
FY2015Q1
FY2014Q4
FY2014Q3
營業總收入
-9.50%15.05M
78.79%23.02M
51.27%13.78M
104.76%14.24M
-42.54%16.63M
771.57%12.87M
-24.02%9.11M
-48.82%6.96M
129.53%28.93M
-114.12%-1.92M
-9.60%11.99M
-3.11%13.59M
12.03%12.61M
5.59%13.57M
84.15%13.27M
114.20%14.03M
74.58%11.25M
94.91%12.85M
-67.58%7.20M
-59.72%6.55M
-50.10%6.45M
-39.69%6.59M
109.31%22.22M
46.28%16.26M
23.80%12.92M
38.78%10.94M
43.30%10.62M
44.82%11.12M
39.68%10.43M
18.18%7.88M
1.24%7.41M
29.74%7.68M
20.18%7.47M
18.50%6.67M
50.28%7.32M
40.68%5.92M
249.75%6.21M
232.37%5.63M
188.45%4.87M
205.45%4.21M
38.18%1.78M
--1.69M
--1.69M
--1.38M
--1.29M
--0.00
--0.00
營業收入
-9.50%15.05M
78.79%23.02M
51.27%13.78M
104.76%14.24M
-42.54%16.63M
771.57%12.87M
-24.02%9.11M
-48.82%6.96M
129.53%28.93M
-114.12%-1.92M
-9.60%11.99M
-3.11%13.59M
12.03%12.61M
5.59%13.57M
84.15%13.27M
114.20%14.03M
74.58%11.25M
94.91%12.85M
-67.58%7.20M
-59.72%6.55M
-50.10%6.45M
-39.69%6.59M
109.31%22.22M
46.28%16.26M
23.80%12.92M
38.78%10.94M
43.30%10.62M
44.82%11.12M
39.68%10.43M
18.18%7.88M
1.24%7.41M
29.74%7.68M
20.18%7.47M
18.50%6.67M
50.28%7.32M
40.68%5.92M
249.75%6.21M
232.37%5.63M
188.45%4.87M
205.45%4.21M
38.18%1.78M
--1.69M
--1.69M
--1.38M
--1.29M
--0.00
--0.00
營業費用
-15.90%115.58M
-18.48%121.73M
-18.60%125.26M
-14.90%124.24M
-3.85%137.43M
8.22%149.32M
7.53%153.88M
0.05%146.00M
14.75%142.94M
11.58%137.97M
20.46%143.10M
29.91%145.93M
-19.89%124.56M
32.58%123.66M
50.00%118.80M
48.65%112.33M
194.11%155.50M
90.37%93.27M
57.38%79.20M
53.29%75.57M
15.02%52.87M
20.36%48.99M
40.00%50.32M
27.79%49.30M
34.23%45.96M
42.20%40.71M
14.08%35.94M
23.36%38.58M
14.53%34.24M
-8.79%28.63M
35.85%31.51M
42.57%31.27M
56.02%29.90M
90.79%31.38M
84.56%23.19M
96.68%21.93M
126.22%19.16M
128.97%16.45M
151.87%12.57M
132.38%11.15M
241.43%8.47M
193.58%7.18M
480.79%4.99M
--4.80M
--2.48M
--2.45M
--859.00K
研發費用
-25.54%80.74M
-24.15%88.65M
-23.21%94.75M
-15.04%97.03M
-3.06%108.43M
7.25%116.88M
8.52%123.38M
-0.93%114.21M
15.17%111.85M
8.94%108.98M
17.64%113.70M
27.80%115.28M
-27.03%97.12M
40.57%100.03M
59.79%96.65M
53.18%90.20M
238.87%133.09M
86.13%71.16M
52.14%60.49M
55.90%58.88M
13.35%39.28M
20.48%38.23M
44.50%39.76M
48.35%37.77M
46.15%34.65M
59.31%31.73M
18.40%27.51M
8.49%25.46M
5.41%23.71M
-5.91%19.92M
32.93%23.24M
50.77%23.47M
67.47%22.49M
86.83%21.17M
122.38%17.48M
109.69%15.56M
157.05%13.43M
158.99%11.33M
127.33%7.86M
277.57%7.42M
281.11%5.22M
374.51%4.38M
1910.47%3.46M
--1.97M
--1.37M
--922.00K
--172.00K
折舊攤銷及損耗
-11.85%2.20M
-7.25%2.38M
-7.40%2.42M
-4.81%2.47M
-0.56%2.50M
--2.57M
13.89%2.61M
19.77%2.60M
22.54%2.51M
----
17.44%2.29M
18.13%2.17M
16.88%2.05M
7.52%2.03M
9.18%1.95M
12.42%1.84M
10.25%1.75M
17.92%1.89M
11.49%1.79M
4.34%1.63M
3.24%1.59M
1.20%1.60M
15.84%1.60M
18.46%1.57M
18.63%1.54M
29.01%1.58M
20.05%1.38M
23.21%1.32M
28.36%1.30M
47.30%1.23M
45.82%1.15M
50.91%1.07M
53.33%1.01M
105.68%833.00K
198.11%790.00K
187.85%711.00K
252.94%660.00K
206.82%405.00K
176.04%265.00K
268.66%247.00K
466.67%187.00K
4300.00%132.00K
--96.00K
--67.00K
--33.00K
--3.00K
--0.00
營業利潤
16.78%-100.53M
27.66%-98.71M
23.00%-111.48M
20.89%-110.00M
-5.97%-120.81M
2.46%-136.45M
-10.42%-144.77M
-5.07%-139.04M
-1.83%-114.00M
-27.07%-139.89M
-24.24%-131.11M
-34.62%-132.33M
22.38%-111.96M
-36.90%-110.09M
-46.58%-105.53M
-42.43%-98.30M
-210.71%-144.25M
-89.66%-80.42M
-156.18%-71.99M
-108.93%-69.02M
-40.48%-46.42M
-42.42%-42.40M
-10.95%-28.10M
-20.30%-33.03M
-38.80%-33.05M
-43.50%-29.77M
-5.10%-25.33M
-16.38%-27.46M
-6.15%-23.81M
16.06%-20.75M
-51.80%-24.10M
-47.31%-23.59M
-73.23%-22.43M
-128.38%-24.71M
-106.25%-15.88M
-130.59%-16.02M
-93.43%-12.95M
-97.09%-10.82M
-133.17%-7.70M
-102.98%-6.95M
-460.17%-6.69M
-124.40%-5.49M
-284.28%-3.30M
---3.42M
---1.20M
---2.45M
---859.00K
淨非營業利息收入(費用)
利息收入
-39.50%5.21M
-39.08%6.48M
-44.61%6.71M
-40.41%7.40M
-31.90%8.60M
-14.67%10.63M
-4.85%12.12M
-1.83%12.42M
5.44%12.63M
132.70%12.46M
555.01%12.74M
1699.86%12.65M
2118.52%11.98M
964.41%5.35M
457.31%1.94M
233.18%703.00K
145.45%540.00K
143.00%503.00K
33.21%349.00K
-67.08%211.00K
-82.29%220.00K
-86.15%207.00K
-84.53%262.00K
-63.93%641.00K
-33.55%1.24M
-11.01%1.50M
21.26%1.69M
29.14%1.78M
74.02%1.87M
123.40%1.68M
169.17%1.40M
224.53%1.38M
238.80%1.07M
190.35%752.00K
141.40%519.00K
821.74%424.00K
6240.00%317.00K
--259.00K
--215.00K
--46.00K
--5.00K
----
----
----
--0.00
----
----
股權收益
----
--0.00
----
----
----
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
-45.57%-4.73M
-110.31%-3.86M
-23.00%-4.00M
-11.04%-3.05M
-145.13%-3.25M
---1.83M
---3.25M
---2.75M
---1.32M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
特殊收入(費用)
57.46%-904.00K
-15.25%-3.55M
212.24%3.44M
106.58%1.34M
64.96%-2.13M
---3.08M
---3.06M
---20.35M
-5965.00%-6.07M
100.00%0.00
100.00%0.00
-100.00%0.00
76.25%-100.00K
---5.43M
---7.81M
--172.00K
---421.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
--0.00
100.00%0.00
--0.00
----
--0.00
---6.05M
稅前利潤
15.83%-96.23M
25.69%-95.79M
25.34%-101.32M
31.11%-101.25M
-6.42%-114.33M
2.47%-128.90M
-11.04%-135.71M
-18.83%-146.97M
-4.18%-107.44M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
-92.54%-81.24M
-157.34%-71.64M
-112.41%-68.81M
-45.27%-46.20M
-49.21%-42.19M
-17.80%-27.84M
-26.13%-32.39M
-44.97%-31.81M
-48.31%-28.28M
-4.11%-23.63M
-15.59%-25.68M
-2.73%-21.94M
20.44%-19.07M
-47.84%-22.70M
-42.49%-22.22M
-69.08%-21.36M
-126.86%-23.96M
-105.24%-15.36M
-125.99%-15.59M
-88.83%-12.63M
-92.37%-10.56M
-126.66%-7.48M
-101.64%-6.90M
-459.75%-6.69M
-124.40%-5.49M
52.26%-3.30M
---3.42M
---1.20M
---2.45M
---6.91M
所得稅
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
100.00%0.00
100.00%0.00
100.00%0.00
100.00%0.00
---246.00K
---282.00K
---382.00K
---102.00K
--0.00
--0.00
除稅後利潤
15.83%-96.23M
25.69%-95.79M
25.34%-101.32M
31.11%-101.25M
-6.42%-114.33M
2.47%-128.90M
-11.04%-135.71M
-18.83%-146.97M
-4.18%-107.44M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
-92.54%-81.24M
-157.34%-71.64M
-112.41%-68.81M
-45.27%-46.20M
-49.21%-42.19M
-17.80%-27.84M
-26.13%-32.39M
-44.97%-31.81M
-48.31%-28.28M
-4.11%-23.63M
-15.59%-25.68M
-2.73%-21.94M
20.44%-19.07M
-47.84%-22.70M
-42.49%-22.22M
-69.08%-21.36M
-126.86%-23.96M
-105.24%-15.36M
-125.99%-15.59M
-88.83%-12.63M
-101.39%-10.56M
-147.83%-7.48M
-126.97%-6.90M
-511.99%-6.69M
-114.34%-5.25M
56.33%-3.02M
---3.04M
---1.09M
---2.45M
---6.91M
持續經營利潤
15.83%-96.23M
25.69%-95.79M
25.34%-101.32M
31.11%-101.25M
-6.42%-114.33M
2.47%-128.90M
-11.04%-135.71M
-18.83%-146.97M
-4.18%-107.44M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
-92.54%-81.24M
-157.34%-71.64M
-112.41%-68.81M
-45.27%-46.20M
-49.21%-42.19M
-17.80%-27.84M
-26.13%-32.39M
-44.97%-31.81M
-48.31%-28.28M
-4.11%-23.63M
-15.59%-25.68M
-2.73%-21.94M
20.44%-19.07M
-47.84%-22.70M
-42.49%-22.22M
-69.08%-21.36M
-126.86%-23.96M
-105.24%-15.36M
-125.99%-15.59M
-88.83%-12.63M
-101.39%-10.56M
-147.83%-7.48M
-126.97%-6.90M
-511.99%-6.69M
-114.34%-5.25M
56.33%-3.02M
---3.04M
---1.09M
---2.45M
---6.91M
歸属于母公司的淨利潤
15.83%-96.23M
25.69%-95.79M
25.34%-101.32M
31.11%-101.25M
-6.42%-114.33M
2.47%-128.90M
-11.04%-135.71M
-18.83%-146.97M
-4.18%-107.44M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
-92.54%-81.24M
-157.34%-71.64M
-112.41%-68.81M
-45.27%-46.20M
-49.21%-42.19M
-17.80%-27.84M
-26.13%-32.39M
-44.97%-31.81M
-48.31%-28.28M
-4.11%-23.63M
-15.59%-25.68M
-2.73%-21.94M
20.44%-19.07M
-47.84%-22.70M
-42.49%-22.22M
-69.08%-21.36M
-126.86%-23.96M
-105.24%-15.36M
-125.99%-15.59M
-88.83%-12.63M
-101.39%-10.56M
-147.83%-7.48M
-126.97%-6.90M
-511.99%-6.69M
-114.34%-5.25M
56.33%-3.02M
---3.04M
---1.09M
---2.45M
---6.91M
歸屬普通股東的淨利潤
15.83%-96.23M
25.69%-95.79M
25.34%-101.32M
31.11%-101.25M
-6.42%-114.33M
2.47%-128.90M
-11.04%-135.71M
-18.83%-146.97M
-4.18%-107.44M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
-92.54%-81.24M
-157.34%-71.64M
-112.41%-68.81M
-45.27%-46.20M
-49.21%-42.19M
-17.80%-27.84M
-26.13%-32.39M
-44.97%-31.81M
-48.31%-28.28M
-4.11%-23.63M
-15.59%-25.68M
-2.73%-21.94M
20.44%-19.07M
-47.84%-22.70M
-42.49%-22.22M
-69.08%-21.36M
-126.86%-23.96M
-105.24%-15.36M
-125.99%-15.59M
-88.83%-12.63M
-101.39%-10.56M
-147.83%-7.48M
-126.97%-6.90M
-511.99%-6.69M
-114.34%-5.25M
56.33%-3.02M
---3.04M
---1.09M
---2.45M
---6.91M
基本每股收益
26.48%-0.81
34.73%-0.83
31.56%-0.92
35.60%-0.98
1.81%-1.10
13.39%-1.27
2.55%-1.34
-8.06%-1.52
4.25%-1.12
-4.68%-1.46
7.40%-1.38
-5.63%-1.40
40.20%-1.17
-27.84%-1.40
-53.18%-1.49
-31.54%-1.33
-185.69%-1.96
-58.59%-1.09
-105.14%-0.97
-66.31%-1.01
-9.18%-0.69
-20.13%-0.69
2.65%-0.47
-8.27%-0.61
-29.87%-0.63
-32.91%-0.57
7.46%-0.49
-8.08%-0.56
4.51%-0.49
29.49%-0.43
-20.53%-0.53
-16.15%-0.52
-39.64%-0.51
-100.26%-0.61
-100.15%-0.44
-23.76%-0.45
-90.86%-0.36
-104.31%-0.31
-153.46%-0.22
-316.60%-0.36
-512.04%-0.19
-114.36%-0.15
56.34%-0.09
---0.09
---0.03
---0.07
---0.20
稀釋每股收益
26.48%-0.81
34.73%-0.83
31.56%-0.92
35.60%-0.98
1.81%-1.10
13.39%-1.27
2.55%-1.34
-8.06%-1.52
4.25%-1.12
-4.68%-1.46
7.40%-1.38
-5.63%-1.40
40.20%-1.17
-27.84%-1.40
-53.18%-1.49
-31.54%-1.33
-185.69%-1.96
-58.59%-1.09
-105.14%-0.97
-66.31%-1.01
-9.18%-0.69
-20.13%-0.69
2.65%-0.47
-8.27%-0.61
-29.87%-0.63
-32.91%-0.57
7.46%-0.49
-8.08%-0.56
4.51%-0.49
29.49%-0.43
-20.53%-0.53
-16.15%-0.52
-39.64%-0.51
-100.26%-0.61
-100.15%-0.44
-23.76%-0.45
-90.86%-0.36
-104.31%-0.31
-153.46%-0.22
-316.60%-0.36
-512.04%-0.19
-114.36%-0.15
56.34%-0.09
---0.09
---0.03
---0.07
---0.20
每股派息
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
貨幣單位
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
審計意見
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

常見問題

如何在 TradingKey 上查看 Intellia Therapeutics Inc 的利潤表?

先看總營收,再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘(EPS)。營收反映公司的業務規模,而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別?

季度利潤表反映公司在一個為期三個月的財務季度內的經營表現,年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化,年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思?

同比(即年增率,YoY)是指將某項財務指標與上年同期進行比較,例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢,同時減少正常季節性變化對分析的影響。

分析 NTLA 股票時,哪些利潤表指標最重要?

重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標,以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Intellia Therapeutics Inc 財年末的營收是多少?

Intellia Therapeutics Inc 2025 財年營收為 67.67M,高於上一財年的 57.88M。

Intellia Therapeutics Inc 最近一個季度的營收是多少?

Intellia Therapeutics Inc 最近一個季度的營收為 15.05M,同比增長 -9.50%。

Intellia Therapeutics Inc 全年的淨利潤是多少?

Intellia Therapeutics Inc 2025 財年淨利潤為 -412.69M。

Intellia Therapeutics Inc 上一季度的淨利潤是多少?

Intellia Therapeutics Inc 最近一個季度的淨利潤為 -96.23M。

Intellia Therapeutics Inc 年度營業利潤是多少?

Intellia Therapeutics Inc 2025 財年的營業利潤為 -440.99M。

每股收益與利潤表有什麼關係?

每股收益(EPS)通常以淨利潤除以流通在外的股份數量計算,用於衡量公司平均每股創造的利潤。分析 EPS 時,還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有